Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pike

Showing results (551-560 of 677) with videos related to

Pageof 68
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Nature Genetics|April 3, 2007
Multiple regions within 8q24 independently affect risk for prostate cancerChristopher A Haiman, Nick Patterson, Matthew L Freedman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2014
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0Ronald Boellaard, Roberto Delgado-Bolton, Wim J G Oyen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2006
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50Robert W Haile, Duncan C Thomas, Valerie McGuire, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
The American Journal of Clinical Nutrition|February 8, 2025
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Pageof 68

Showing results (551-560 of 677) with videos related to

Sort By:
Pageof 68
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Nature Genetics|April 3, 2007
Multiple regions within 8q24 independently affect risk for prostate cancerChristopher A Haiman, Nick Patterson, Matthew L Freedman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2014
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0Ronald Boellaard, Roberto Delgado-Bolton, Wim J G Oyen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2006
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50Robert W Haile, Duncan C Thomas, Valerie McGuire, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
The American Journal of Clinical Nutrition|February 8, 2025
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association ConsortiumChristina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Pageof 68